201 related articles for article (PubMed ID: 10375948)
1. [Extracellular components of bronchoalveolar lavage fluid (BALF) as a marker of the activity of interstitial pulmonary diseases. III: Phospholipids to protein concentration ratio].
Zielonka TM; Wałajtys-Rode E; Jasińska R; Chazan R; Droszcz W
Przegl Lek; 1999; 56(2):144-7. PubMed ID: 10375948
[TBL] [Abstract][Full Text] [Related]
2. [Extracellular components of bronchoalveolar lavage fluid (BALF) as a marker of interstitial pulmonary disease activity. I. Protein concentration].
Zielonka TM; Wałajtys-Rode E; Chazan R; Droszcz W
Przegl Lek; 1998; 55(11):581-5. PubMed ID: 10216371
[TBL] [Abstract][Full Text] [Related]
3. [Extracellular components of broncho-alveolar lavage fluid (BALF) as markers of interstitial pulmonary disease activity. II. Phospholipid concentration].
Zielonka TM; Wałajtys-Rode E; Jasińska R; Chazan R; Droszcz W
Przegl Lek; 1998; 55(12):654-8. PubMed ID: 10354716
[TBL] [Abstract][Full Text] [Related]
4. [Concentration of thromboxane B2 in bronchoalveolar lavage fluid in selected interstitial pulmonary diseases].
Zielonka TM; Rybus L; Doboszyńska A; Wałajtys-Rode E; Walkiewicz R; Droszcz W
Przegl Lek; 1995; 52(6):315-7. PubMed ID: 7568987
[TBL] [Abstract][Full Text] [Related]
5. A comparison of albumin and urea as reference markers in bronchoalveolar lavage fluid from patients with interstitial lung disease.
Jones KP; Edwards JH; Reynolds SP; Peters TJ; Davies BH
Eur Respir J; 1990 Feb; 3(2):152-6. PubMed ID: 2311740
[TBL] [Abstract][Full Text] [Related]
6. [Concentration of alkaline phosphatase (AP) and AP/albumin ratio in bronchoalveolar lavage (BAL) for the diagnosis of interstitial lung diseases].
Schildge J; Klar B; Weinstock N
Pneumologie; 2000 Sep; 54(9):385-91. PubMed ID: 11072722
[TBL] [Abstract][Full Text] [Related]
7. [Concentration of sialic acid in bronchoalveolar lavage fluid in selected interstitial pulmonary diseases].
Zielonka TM; Lasota A; Wałajtys-Rode E; Droszcz P; Chazan R
Pneumonol Alergol Pol; 1995; 63(11-12):627-31. PubMed ID: 8616478
[TBL] [Abstract][Full Text] [Related]
8. Bronchoalveolar lavage fluid protein composition in patients with sarcoidosis and idiopathic pulmonary fibrosis: a two-dimensional electrophoretic study.
Magi B; Bini L; Perari MG; Fossi A; Sanchez JC; Hochstrasser D; Paesano S; Raggiaschi R; Santucci A; Pallini V; Rottoli P
Electrophoresis; 2002 Sep; 23(19):3434-44. PubMed ID: 12373774
[TBL] [Abstract][Full Text] [Related]
9. Elevated matrilysin levels in bronchoalveolar lavage fluid do not distinguish idiopathic pulmonary fibrosis from other interstitial lung diseases.
Vuorinen K; Myllärniemi M; Lammi L; Piirilä P; Rytilä P; Salmenkivi K; Kinnula VL
APMIS; 2007 Aug; 115(8):969-75. PubMed ID: 17696954
[TBL] [Abstract][Full Text] [Related]
10. Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases.
Vasakova M; Sterclova M; Kolesar L; Slavcev A; Pohunek P; Sulc J; Skibova J; Striz I
Scand J Immunol; 2009 Mar; 69(3):268-74. PubMed ID: 19281539
[TBL] [Abstract][Full Text] [Related]
11. Chitotriosidase activity in patients with interstitial lung diseases.
Bargagli E; Margollicci M; Luddi A; Nikiforakis N; Perari MG; Grosso S; Perrone A; Rottoli P
Respir Med; 2007 Oct; 101(10):2176-81. PubMed ID: 17631992
[TBL] [Abstract][Full Text] [Related]
12. Induced sputum in patients with interstitial lung disease: a non-invasive surrogate for certain parameters in bronchoalveolar lavage fluid.
Sobiecka M; Kus J; Demkow U; Filewska M; Jozwik A; Radwan-Rohrenschef P; Chorostowska-Wynimko J
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():645-57. PubMed ID: 19218691
[TBL] [Abstract][Full Text] [Related]
13. [Measurement of small quantities of alpha 2-macroglobulin in bronchoalveolar lavage fluid by enzyme-labelled immunoassay, and its clinical implication in pulmonary disease].
Takasaki M; Bandou Y; Uchiyama Y; Ohtani H; Umehara M; Soma K; Ishikawa K; Katagiri M; Yanase N; Tomita T
Rinsho Byori; 1989 Jul; 37(7):825-9. PubMed ID: 2481759
[TBL] [Abstract][Full Text] [Related]
14. [Mast cells in bronchoalveolar lavage fluid of patients with interstitial lung diseases].
Schildge J; Klar B; Hardung-Backes M
Pneumologie; 2003 Apr; 57(4):202-7. PubMed ID: 12690558
[TBL] [Abstract][Full Text] [Related]
15. [The state of the protease-inhibitor system in the bronchoalveolar lavage of patients with diffuse lung diseases].
Kaminskaia GO; Stepanian IE; Zhukova NL
Vopr Med Khim; 1988; 34(6):100-4. PubMed ID: 3070930
[TBL] [Abstract][Full Text] [Related]
16. [N-terminal peptide of type III procollagen in serum and bronchoalveolar fluid as a marker of collagen metabolism in chronic interstitial lung diseases].
Siemińska A
Przegl Lek; 1996; 53(7):574-8. PubMed ID: 8975295
[TBL] [Abstract][Full Text] [Related]
17. [Procollagen-III-peptide in bronchoalveolar lavage fluid as an index of fibrosis in sarcoidosis and idiopathic lung fibrosis?].
Teschler H; Costabel U; Ziesche R; Freitag L; Matthys H; Konietzko N
Pneumologie; 1990 Feb; 44 Suppl 1():217-8. PubMed ID: 2367369
[TBL] [Abstract][Full Text] [Related]
18. Different expression of endothelin in the bronchoalveolar lavage in patients with pulmonary diseases.
Reichenberger F; Schauer J; Kellner K; Sack U; Stiehl P; Winkler J
Lung; 2001; 179(3):163-74. PubMed ID: 11891606
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of CD30 as a marker for th2 lymphocytes in bronchoalveolar lavage in interstitial lung diseases.
Petkova D; Xaubet A; Picado C; Filella X; Agusti C; Luburich P; Rodriguez-Roisin R
Respir Med; 2000 Apr; 94(4):345-9. PubMed ID: 10845432
[TBL] [Abstract][Full Text] [Related]
20. [A study on enzymatic activities of bronchoalveolar lavage fluid in patients with interstitial lung diseases].
Zheng J; Jia Y; Zhou K
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Feb; 21(2):91-3. PubMed ID: 11263392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
